Resistance to activated protein C (APCR) in children with venous or arterial thromboembolism

British Journal of Haematology

Volumn 92, Issue 4, 1996, Pages 992-998

  Nowak Gottl U ^a,c   Koch, H G ^a   Aschka, I ^b   Kohlhase, B ^a   Vielhaber, H ^a   Kurlemann, G ^a   Oleszcuk Raschke, K ^a   Kehl, H G ^a   Jurgens H ^a   Schneppenheim, R ^b  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^c UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

APCR; children; Gln 506 Arg; neonatal stroke; venous thrombosis

Indexed keywords

ACTIVATED PROTEIN C;

ADOLESCENT; ARTERY THROMBOSIS; ARTICLE; BLOOD CLOTTING DISORDER; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; INFANT; NEWBORN; POINT MUTATION; PRIORITY JOURNAL; STROKE; THROMBOEMBOLISM; VEIN THROMBOSIS;

EID: 0041798768     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1996.424957.x     Document Type: Article

References (15)

1. Amer, L., Kisiel, W., Searles, R.P. & Williams R.C., Jr (1990) Impairment of the protein C anticoagulant pathway in a patient with systemic lupus erythematosus, anticardiolipin antibodies and thrombosis. Thrombosis Research, 57, 247-258.
2. Andrew, M. (1995) Developmental hemostasis: relevance to thromboembolic complications in pediatric patients. Thrombosis and Haemostasis, 74, 415-425.
3. Arnout, J., Vanrusselt, M. & Vermylen, J. (1995) Resistance to activated protein C in a population of patients with antiphospholipid antibodies. Thrombosis and Haemostasis, 73, 1275.
4. Bandello, F., Dàngelo, S.V., Parlavecchia, M., Tavola, A., Valle, P.D., Brancato, R. & Dàngelo, A. (1994) Hypercoagulability and high lipoprotein (a) levels in patients with central retinal vein occlusion. Thrombosis and Haemostasis, 72, 39-43.
5. Bertina, R.M., Koeleman, B.P.C., Koster, T., Rosendaal, F.R., Dirven, R.J., de Ronde, H., van der Velden, P.A. & Reltsma, P.H. (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature, 369, 64-67.
6. Bick, R.L. & Baker, W.F. (1994) The antiphospholipid and thrombosis syndromes. Medical Clinics of North America, 78, 667-684.
7. Dahlbäck, B. (1995) New molecular insights into the genetics of thrombophilia: resistance to activated protein C caused by Arg 506 to Gln mutation in factor V as a pathogenetic risk factor. Thrombosis and Haemostasis, 74, 139-148.
8. Dahlbäck, B. & Carlsson, M. (1991) Factor VIII defect associated with familial thrombophilia. Thrombosis and Haemostasis, 65, 658.
9. Dahlbäck, B., Carlsson, M. & Svensson, P.J. (1993) Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proceedings of the National Academy of Sciences of the United States of America, 90, 1004-1008.
10. Faioni, E.M., Boyer-Neumann, C., Franchi, F., Wolf, M., Meyer, D. & Mannucci, P.M. (1994) Another protein S functional assay is sensitive to resistance to activated protein C. Thrombosis and Haemostasis, 72, 643-651.
11. Koster, T., Rosendaal, F.R., de Ronde, H., Briet, E., Vandenbroucke, J.P. & Bertina, R.M. (1993) Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet, 342, 1503-1506.
12. Mannucci, P.M. & Tripodi, A. (1987) Laboratory screening of inherited thrombotic syndromes. Thrombosis and Haemostasis, 57, 247-251.
13. Rosengren, A., Wilhelmsen, L., Eriksson, E., Risberg, B. & Wedel, H. (1990) Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle-aged men. British Medical Journal, 301, 1248-1251.
14. Simioni, P., De Ronde, H., Prandoni, P., Saladini, M., Bertina, R.M. & Girolami, A. (1995) Ischemic stroke in young patients with activated protein C resistance: a report of three cases belonging to three different kindreds. Stroke, 26, 885-890.
15. Svensson, P.J. & Dahlbäck, B. (1994) Resistance to activated protein C as a basis for venous thrombosis. New England journal of Medicine, 330, 517-522.